BBIO insider buying and SEC filings, explained
BridgeBio Pharma, Inc. · CIK 1743881
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- BridgeBio Pharma LLC
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$6.3M
Planned sales (10b5-1)
$93.3M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 30, 2026 | Planned (10b5-1) | Maricel Apuli (Chief Accounting Officer) sold 2,000 shares at $72.85 ($146K), marked as a 10b5-1 plan trade. Holdings down 2% to 120,687 shares. | SEC filing Filed Nov 3, 2026, 4:14 PM ET |
| Sep 17, 2026 | Planned (10b5-1) | Neil Kumar (CEO and Director) sold 10,000 shares indirectly (by trust) at about $69.08 ($691K), marked as a 10b5-1 plan trade. Holdings by trust down 2% to 495,686 shares. | SEC filing Filed Sep 21, 2026 |
| Aug 18–19, 2026 | Planned (10b5-1) | Neil Kumar (CEO and Director) sold 44,980 shares directly and indirectly (by trust) between Aug 18 and Aug 19 at about $82.86 ($3.7M), marked as a 10b5-1 plan trade. Direct holdings down 13% to 243,327 shares. | SEC filing Filed Aug 20, 2026 |
| Jul 30, 2026 | Planned (10b5-1) | Maricel Apuli (Chief Accounting Officer) sold 2,000 shares at $80.06 ($160K), marked as a 10b5-1 plan trade. Holdings down 2% to 127,401 shares. | SEC filing Filed Aug 3, 2026 |
| Jul 9, 2026 | Planned (10b5-1) | Andrea Ellis (Director) sold 17,167 shares at $84.00 ($1.4M), marked as a 10b5-1 plan trade. Holdings down 43% to 22,579 shares. | SEC filing Filed Jul 13, 2026 |
| Jul 9, 2026 | Planned (10b5-1) | Jennifer E. Cook (Director) sold 148,589 shares at about $88.54 ($13.2M), marked as a 10b5-1 plan trade. Holdings down 95% to 8,383 shares. | SEC filing Filed Jul 13, 2026 |
| Jun 23–24, 2026 | Planned (10b5-1) | Jennifer E. Cook (Director) sold 39,363 shares between Jun 23 and Jun 24 at about $69.92 ($2.8M), marked as a 10b5-1 plan trade. Holdings down 82% to 8,383 shares. | SEC filing Filed Jun 24, 2026 |
| Jun 22–23, 2026 | Planned (10b5-1) | Hannah Valantine (Director) sold 5,004 shares between Jun 22 and Jun 23 at about $68.25 ($342K), marked as a 10b5-1 plan trade. Holdings down 35% to 9,259 shares. | SEC filing Filed Jun 24, 2026 |
| Jun 15, 2026 | Planned (10b5-1) | Jennifer E. Cook (Director) sold 90,240 shares at about $66.63 ($6.0M), marked as a 10b5-1 plan trade. Holdings down 93% to 6,589 shares. | SEC filing Filed Jun 17, 2026 |
| Jun 4–5, 2026 | Planned (10b5-1) | Neil Kumar (CEO and Director) sold 80,000 shares indirectly (by trust) between Jun 4 and Jun 5 at about $67.67 ($5.4M), marked as a 10b5-1 plan trade. Holdings by trust down 7% to 515,686 shares. | SEC filing Filed Jun 8, 2026 |
| May 21, 2026 | Planned (10b5-1) | Neil Kumar (CEO and Director) sold 26,103 shares at about $69.44 ($1.8M), marked as a 10b5-1 plan trade. Holdings down 10% to 243,327 shares. | SEC filing Filed May 26, 2026 |
| May 18, 2026 | Planned (10b5-1) | Thomas Trimarchi (CFO) sold 13,651 shares at about $65.08 ($888K), marked as a 10b5-1 plan trade. Holdings down 4% to 359,194 shares. | SEC filing Filed May 19, 2026 |
| May 15, 2026 | Planned (10b5-1) | Randal W. Scott (Director) sold 10,000 shares at about $67.15 ($671K), marked as a 10b5-1 plan trade. Holdings down 46% to 11,589 shares. | SEC filing Filed May 19, 2026 |
| May 7–8, 2026 | Planned (10b5-1) | Neil Kumar (CEO and Director) sold 80,000 shares indirectly (by trust) between May 7 and May 8 at about $67.40 ($5.4M), marked as a 10b5-1 plan trade. Holdings by trust down 7% to 555,686 shares. | SEC filing Filed May 11, 2026 |
| Apr 30, 2026 | Planned (10b5-1) | Maricel Apuli (Chief Accounting Officer) sold 2,000 shares at $71.58 ($143K), marked as a 10b5-1 plan trade. Holdings down 1% to 134,115 shares. | SEC filing Filed May 4, 2026 |
| Apr 9–10, 2026 | Planned (10b5-1) | Neil Kumar (CEO and Director) sold 80,000 shares indirectly (by trust) between Apr 9 and Apr 10 at about $74.61 ($6.0M), marked as a 10b5-1 plan trade. Holdings by trust down 6% to 595,686 shares. | SEC filing Filed Apr 13, 2026 |
| Mar 12–13, 2026 | Planned (10b5-1) | Neil Kumar (CEO and Director) sold 80,000 shares indirectly (by trust) between Mar 12 and Mar 13 at about $68.76 ($5.5M), marked as a 10b5-1 plan trade. Holdings by trust down 6% to 635,686 shares. | SEC filing Filed Mar 16, 2026 |
| Mar 10, 2026 | Planned (10b5-1) | Hannah Valantine (Director) sold 8,671 shares at $72.00 ($624K), marked as a 10b5-1 plan trade. Holdings down 54% to 7,465 shares. | SEC filing Filed Mar 12, 2026 |
| Mar 4, 2026 | Planned (10b5-1) | Andrea Ellis (Director) sold 64,921 shares at about $64.87 ($4.2M), marked as a 10b5-1 plan trade. Holdings down 78% to 18,589 shares. | SEC filing Filed Mar 6, 2026 |
| Feb 27, 2026 | Planned (10b5-1) | Hannah Valantine (Director) sold 25,484 shares at about $67.41 ($1.7M), marked as a 10b5-1 plan trade. Holdings down 77% to 7,465 shares. | SEC filing Filed Mar 3, 2026 |
| Feb 26, 2026 | Planned (10b5-1) | Maricel Apuli (Chief Accounting Officer) sold 2,000 shares at $66.00 ($132K), marked as a 10b5-1 plan trade. Holdings down 2% to 121,945 shares. | SEC filing Filed Feb 27, 2026 |
| Feb 19, 2026 | Planned (10b5-1) | Neil Kumar (CEO and Director) sold 28,053 shares at about $71.39 ($2.0M), marked as a 10b5-1 plan trade. Holdings down 11% to 234,451 shares. | SEC filing Filed Feb 23, 2026 |
| Feb 17, 2026 | Planned (10b5-1) | Randal W. Scott (Director) sold 10,000 shares at about $75.46 ($755K), marked as a 10b5-1 plan trade. Holdings down 46% to 11,589 shares. | SEC filing Filed Feb 18, 2026 |
| Feb 17, 2026 | Planned (10b5-1) | Maricel Apuli (Chief Accounting Officer) sold 510 shares at $74.31 ($38K), marked as a 10b5-1 plan trade. Holdings down <1% to 123,945 shares. | SEC filing Filed Feb 18, 2026 |
| Feb 17, 2026 | Planned (10b5-1) | Thomas Trimarchi (CFO) sold 13,600 shares at about $74.72 ($1.0M), marked as a 10b5-1 plan trade. Holdings down 4% to 336,585 shares. | SEC filing Filed Feb 18, 2026 |
| Feb 10–11, 2026 | Planned (10b5-1) | Neil Kumar (CEO and Director) sold 80,000 shares indirectly (by trust) between Feb 10 and Feb 11 at about $71.86 ($5.7M), marked as a 10b5-1 plan trade. Holdings by trust down 6% to 675,686 shares. | SEC filing Filed Feb 12, 2026 |
| Jan 8–9, 2026 | Planned (10b5-1) | Neil Kumar (CEO and Director) sold 80,000 shares indirectly (by trust) between Jan 8 and Jan 9 at about $75.54 ($6.0M), marked as a 10b5-1 plan trade. Holdings by trust down 5% to 715,686 shares. | SEC filing Filed Jan 12, 2026 |
| Dec 15, 2025 | Planned (10b5-1) | Neil Kumar (CEO and Director) sold 30,011 shares at about $74.64 ($2.2M), marked as a 10b5-1 plan trade. Holdings down 12% to 228,776 shares. | SEC filing Filed Dec 16, 2025 |
| Dec 8, 2025 | Planned (10b5-1) | Maricel Apuli (Chief Accounting Officer) sold 2,000 shares at $74.26 ($149K), marked as a 10b5-1 plan trade. Holdings down 2% to 130,297 shares. | SEC filing Filed Dec 10, 2025 |
| Dec 4–5, 2025 | Planned (10b5-1) | Neil Kumar (CEO and Director) sold 80,000 shares indirectly (by trust) between Dec 4, 2025 and Dec 5, 2025 at about $73.86 ($5.9M), marked as a 10b5-1 plan trade. Holdings by trust down 5% to 755,686 shares. | SEC filing Filed Dec 8, 2025 |
| Nov 20, 2025 | Planned (10b5-1) | Neil Kumar (CEO and Director) sold 26,156 shares at about $65.84 ($1.7M), marked as a 10b5-1 plan trade. Holdings down 10% to 228,776 shares. | SEC filing Filed Nov 24, 2025 |
| Nov 17–18, 2025 | Sale | Andrew Lo (Director) sold 95,599 shares directly and indirectly between Nov 17, 2025 and Nov 18, 2025 at about $66.11 ($6.3M). Direct holdings down 74% to 14,089 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 19, 2025 |
| Nov 17, 2025 | Planned (10b5-1) | Randal W. Scott (Director) sold 10,000 shares at about $66.65 ($666K), marked as a 10b5-1 plan trade. Holdings down 46% to 11,589 shares. | SEC filing Filed Nov 19, 2025 |
| Nov 17, 2025 | Planned (10b5-1) | Thomas Trimarchi (CFO) sold 16,934 shares at about $66.46 ($1.1M), marked as a 10b5-1 plan trade. Holdings down 4% to 382,830 shares. | SEC filing Filed Nov 18, 2025 |
| Nov 6–7, 2025 | Planned (10b5-1) | Neil Kumar (CEO and Director) sold 80,000 shares indirectly (by trust) between Nov 6, 2025 and Nov 7, 2025 at about $62.29 ($5.0M), marked as a 10b5-1 plan trade. Holdings by trust down 1% to 4,598,447 shares. | SEC filing Filed Nov 10, 2025 |
44 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Oct 29, 2026, 4:03 PM ET 8-K | Earnings released (Item 2.02) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow BBIO in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.